Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 14Polycystic Ovary Syndrome 9Neoplasms 5Endometrial Neoplasms 3Prostatic Neoplasms 2Peripheral Nervous System Diseases 2Obesity 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Leukemia, Myeloid, Acute 2Leiomyoma 2Insulin Resistance 2Inflammation 2Infertility, Female 2Glioblastoma 2Diabetes Mellitus 2Colorectal Neoplasms 2Cognitive Dysfunction 2Cardiotoxicity 2Weight Gain 1Vomiting 1Venous Thromboembolism 1Vascular Malformations 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Stem Cell Transplant Complications 1

Interventions

Fulvestrant 6olaparib 4Letrozole 4trastuzumab deruxtecan 3Aromatase Inhibitors 3Anastrozole 3sacituzumab govitecan 2pyrotinib 2eribulin 2dalpiciclib 2Paclitaxel 2Goserelin 2Gonadotropin-Releasing Hormone 2FCN-437c 2Capecitabine 2toripalimab 1talazoparib 1sonidegib 1ribociclib 1pembrolizumab 1neratinib 1liposomal doxorubicin 1elacestrant 1disitamab vedotin 1ceralasertib 1capivasertib 1balixafortide 1apatinib 1abemaciclib 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Breast Cancer × Tablets × Clear all
NCT03405168 2018-11-16

Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer

Sun Yat-sen University

Phase 2 Completed
35 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡